PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.970
+0.220 (4.63%)
At close: Jun 29, 2026, 4:00 PM EDT
4.910
-0.060 (-1.21%)
Pre-market: Jun 30, 2026, 7:57 AM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $95.3 million as of June 30, 2026. Its market cap has increased by 172.62% in one year.
Market Cap
95.30M
Enterprise Value
86.73M
1-Year Change
172.62%
Ranking
Category
Stock Price
$4.97
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $95.30M, an increase of 15.60%. That is a compound annual growth rate of 2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 95.30M | 32.00% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 92.07M |
| Fortress Biotech | 91.68M |
| Seer, Inc. | 91.27M |
| Rani Therapeutics Holdings | 91.17M |
| Inovio Pharmaceuticals | 90.50M |
| Rein Therapeutics | 90.36M |
| NeurAxis | 90.03M |
| Lixte Biotechnology Holdings | 89.03M |